Characterization of ribonucleases and ribonuclease inhibitor in subcellular fractions from rat adrenals by Girija, N. S. & Sreenivasan, A.
Biochem. J. (1966) 98, 562
Characterization of Ribonucleases and Ribonuclease Inhibitor in
Subcellular Fractions from Rat Adrenals
By N. S. GIRIJA Aim A. SREENIVASAN
Biochemi8try and Food Technology Divi8ion, Atomic Energy E8tabli8hment Trombay, Bombay, India
(Received 9 August 1965)
1. The presence of two RNA-degrading enzymes, one with optimum activity at
pH5-6 (acid ribonuclease) and the other with optimum activity at pH7-8
(alkaline ribonuclease), in rat adrenals has been demonstrated. The acid ribo-
nucleasewas localized in themitochondrialfractionwhereasthealkalineribonuclease
was present in mitochondria as well as in the supernatant fraction. Freezing and
thawing of mitochondria and treatment with Triton X-100 gave a three- to four-
fold increase in acid-ribonuclease activity, whereas the mitochondrial alkaline-
ribonuclease activity was practically unaffected. 2. The amount offree ribonuclease
in the adrenal supernatant was small. Treatment of the supernatant fraction
with N-ethylmaleimide resulted in release oflarge amounts ofribonuclease activity,
indicating the presence of a ribonuclease inhibitor having reactive thiol groups.
3. Considerable amounts of free ribonuclease inhibitor in excess over the bound
alkaline ribonuclease are present in the rat-adrenal supernatant fraction. The
inhibitor is heat-labile and non-diffusible. A 400-500-fold purification of the
ribonuclease inhibitor was achieved by ammonium sulphate fractionation, treat-
ment with calcium phosphate gel and DEAE-cellulose chromatography. It is
concluded that the adrenal inhibitor is protein in nature, similar to the inhibitor
present in rat liver.
Roth (1956a, 1957) has reported the presence of
an inhibitor for ribonuclease activity in rat-liver
supernatant fraction. Shortman (1961) has demon-
strated from purification studies of the rat-liver
inhibitor that the inhibitor activity is associated
with a fraction that is mostly protein. Eichel,
Figueroa & Goldenberg (1961) have provided
evidence for the presence of ribonuclease inhibitor
in rat adipose tissue.
There have been a number of attempts to assess
the possible role of the ribonuclease inhibitor in
RNA metabolism and protein synthesis by deter-
mining the changes in the concentrations of ribo-
nuclease and ribonuclease inhibitor after altered
physiological states in the organism. Thus the
changes in inhibitor activity have been studied in
rat liver after whole-body X-irradiation (Roth,
1956b) or during regeneration after partial hepatec-
tomy (Shortman, 1962b) and in different cancerous
tissues (Brody, 1957; Roth, 1962). Girija, Pradhan
& Sreenivasan (1965) have reported on the correla-
tion observed between altered protein-synthetic
activity and the ribonuclease inhibitor concentra-
tions in livers of rats maintained on protein-free
diet for 3 weeks. Smeaton, Elliott & Coleman (1965)
have found a powerful inhibitor of ribonuclease
activity in the soluble fraction of disrupted cell
preparations of a strain of Bacillw subtili. They
have also provided preliminary evidence for the
protein nature of this bacterial ribonuclease
inhibitor.
Thus these observations call for a detailed under-
standing of the cellular inhibitors of ribonuclease
from a wide variety of sources, with special refer-
ence to their intracellular location, specificity and
mode of inhibition. The present work reports on
the distribution of ribonuclease activity in the sub-
cellular fractions of rat adrenals and the presence
of an inhibitor of ribonuclease activity in the
adrenal supernatant fraction. The inhibitor has
been purified by chromatography on DEAE-
cellulose columns.
EXPERIMENTAL
Animals. Livers and adrenals were obtained from male
Wistar rats, maintained on the laboratory stock diet, and
weighing 250-300g.
Preparation of aubceUular fractions. The tissues were
dissected and homogenized with 10vol. of 0-25x-sucrose,
previously chilled, in a Potter-Elvehjem glass homogenizer.
The isolation of subcellular fractions was done according to
the procedure of Schneider & Hogeboom (1945). The
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homogenate was centrifuged at 500g in an International
model PR-2 refrigerated centrifuge to remove nuclei and
unbroken cells. Mitochondria were separated at 5000g for
15min. These were washed twice with 10vol. of 0-25M-
sucrose and recentrifuged under the same conditions. The
resulting mitochondrial pellet was suspended in 10vol. of
0-25M-sucrose for the assay of free ribonuclease activity.
Total ribonuclease activity was determined after freezing
and thawing a 1:10 suspension of mitochondria in water or
after treatment with Triton X-100 (0.1%, v/v) at 40 for
20min.
The supernatant obtained after sedimenting mitochon-
dria was spun in a Spinco model L ultracentrifuge at
105000g for 1 hr. and the resulting supernatant fraction
was used in the studies on the ribonuclease inhibitor.
Determination of ribonuclease activity. Ribonuclease
activity was determined as described by Brody (1957), by
following the release of acid-soluble nucleotides on incuba-
tion of 2-5mg. of dialysed yeast RNA with a 1:10 homo-
genate or equivalent cell fraction in a final volume of
3-Oml. Incubations at 370 were carried out in 20mM-tris-
HCI buffer, pH7-8, for the determination of alkaline-
ribonuclease activity and in 20mM-acetate buffer, pH5-6,
for the assay of acid-ribonuclease activity. For the super-
natant enzyme, preincubation of the supernatant fraction
with N-ethylmaleimide (final concn. 3mm) was carried
out for 30min. before incubation with the substrate.
The reaction was stopped by the addition of 3-Oml.
of 10% (w/v) trichloroacetic acid containing uranyl
acetate (0-5%), and the acid-soluble nucleotides were deter-
mined by measuring the extinction at 290mu in a Beckman
model DU spectrophotometer, trichloroacetic acid giving
negligible extinction at this wavelength. The amount of
enzyme releasing acid-soluble nucleotides equivalent to
1 extinction unit under the above conditions is expressed
as 1 ribonuclease unit.
Assay of ribonudea8e inhibitor. The system for the assay
of ribonuclease inhibitor (Roth & Wojner, 1961) consisted
of 0-2 ml. of supernatant fraction, 0-15 ml. of 50mM-EDTA,
pH7-8, 0125/Lg. of crystalline pancreatic ribonuclease
(Worthington Biochemical Corp., Freehold, N.J., U.S.A.),
1-Oml. of veronal-acetate buffer (50mM with respect to
both sodium diethylbarbiturate and sodium acetate),
pH7-8, and 1-Oml. of 1% RNA solution in a final volume
of 3-Oml. Incubation was carried out for 30min. at 37°.
The reaction was stopped by the addition of 3-0ml. of
precipitating reagent [N-HC1 in 76% (v/v) ethanol con-
taining LaC13,7H20 (0-5%)]. Release of acid-soluble
nucleotides was estimated by the change in extinction at
260m,u. One unit of inhibitor is equivalent to the concen-
tration causing 50% inhibition of 0-005,ug. of crystalline
pancreatic ribonuclease.
Purification of ribonuclea8e inhibitor. Sheep adrenals
contained inhibitor activity comparable with that from rat
adrenals. The inhibitor from sheep adrenals resembled the
rat-liver inhibitor in all its characteristics, being heat-labile,
non-diffusible and containing active thiol groups.
A 30g. portion of sheep adrenals was homogenized in
3 vol. of 0-25M-sucrose and the supernatant fraction
obtained by spinning the homogenate at 105000g was
treated with solid (NH4)2SO4 to give 35% saturation. The
precipitate was removed by centrifugation at 60000g in
the Spinco model L ultracentrifuge for 20min. Then
(NH4)2SO4 was added to the supernatant to give 55%
saturation and the mixture was centrifuged at 60000g for
20min. The pellet was dissolved in 20ml. of cold water and
this was treated with calcium phosphate gel, prepared
according to the method of Swingle & Tiselius (1951). The
inhibitor was eluted from the gel with 20-25ml. of 0-2M-
phosphate buffer, pH6-4. The eluate was diluted to give a
phosphate concentration of 10mM and NaCl and EDTA
were added to give concentrations of 0-1M and 1mM
respectively. This solution was applied to DEAE-cellulose
columns. The chromatography on DEAE-cellulose columns
was essentially as described by Shortman (1961). The
column was washed with 50ml. of buffered saline [NaCl
(0-15M), potassium phosphate buffer, pH6-4 (10mm), and
EDTA (1mM)]. The elution was carried out with a linear
gradient of 0-15-1-5M-NaCl in 10mM-phosphate buffer,
pH6-4, containing EDTA (1mM). The eluate was collected
in 5-Oml. fractions.
Determination of protein. Protein was determined by the
method of Lowry, Rosebrough, Farr & Randall (1951).
RESULTS AND DISCUSSION
Two apparently distinct enzymes from various
tissues that hydrolyse RNA have been described
by Roth (1954), Stevens & Reid (1956), Maver &
Greco (1956) and Zytko, De Lamirande, Cantero &
Allard (1958). The activities of these have been
differentiated on the basis of pH optima and
stability to heat and acid, one enzyme being termed
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Fig. 1. Effect of pH on the ribonuclease activity of rat-
adrenal homogenate. Samples of rat-adrenal homogenate
equivalent to 50mg. of tissue were incubated with 2-5mg.
of dialysed yeast RNA at 370 for 30 min. in veronal-acetate
buffers in the pH range 4-0-8-5. The reaction was stopped
by the addition of 3-Oml. of 10% (w/v) trichloroacetic acid
containing uranyl acetate (0-5%), and the acid-soluble
nucleotides were determined by measuring the extinction
at 290m,. One unit of ribonuclease activity is the amount
of enzyme releasing acid-soluble nucleotides equivalent to
1 extinction unit under the above conditions. The plot
represents the average of three different experiments.
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alkaline ribonuclease (optimum pH7-8-8-2, heat-
stable and acid-stable) and the other acid ribo-
nuclease (optimum pH 5-2-5-8, heat-labile and acid-
labile). Fig. 1 illustrates the pH-activity curve of
ribonuclease in adrenal homogenate. The curve
reveals two peaks of activity, one at pH5-6 and
another at pH 7-8. These results indicate that rat
adrenals contain both acid and alkaline ribo-
nucleases with pH optima similar to those reported
for the ribonucleases of rat liver (Roth, 1957).
The distribution of acid and alkaline ribo-
nucleases in the subcellular fractions ofrat liver and
adrenals is shown in Table 1. The acid-ribonuclease
activity is localized in the mitochondrial fraction,
the activity in the supernatant fraction being neg-
ligible. Alkaline-ribonuclease activity is present in
mitochondria as well as in the supernatant fraction.
The ribonuclease activity in the supernatant frac-
tion is low. But, on the addition of N-ethylmale-
imide, a 3-4-fold increase in the activity is observed.
The same extent of release of supernatant enzyme
was obtained when p-chloromercuribenzoate was
present in the incubation system at a final concen-
tration of 0-4mm. These results are similar to those
reported for rat liver (Roth, 1958). Calculation of
the distribution of alkaline-ribonuclease activity
between mitochondria and supernatant shows that
about 60% of the ribonuclease activity could be
recovered in the supernatant fraction, after taking
into account the ribonuclease activity released on
treatment with N-ethylmaleimide, and about 20%
in the mitochondria. Experiments showed that
mitochondrial activity is not increased on treatment
of mitochondria with N-ethylmaleimide. However,
other treatments, such as freezing and thawing and
treatment with detergents like Triton X-100,
increase the mitochondrial ribonuclease activity.
The increase is mainly in the acid-ribonuclease
activity, alkaline-ribonuclease activity being un-
affected by these treatments (Table 1).
These results demonstrate that, as in rat
liver, a major part of the ribonuclease activity in
the adrenals is present in a latent form, the super-
natant enzyme occurring in combination with an
inhibitor, which could be inactivated by thiol-
binding reagents, and the mitochondrial acid-
ribonuclease activity present presumably as a
membrane component.
The significance of the intracellular location of
acid and alkaline ribonucleases of mitochondria is
not known, though attempts have been made to
study the characteristics of the two enzymes
(Stevens & Reid, 1956; Zytko et al. 1958; Maver
& Greco, 1962). Nodes, Reid & Whitcut (1962),
working with purified enzymes, found minor
differences in their specificities towards synthetic
substrates. However, one difference between acid
and alkaline ribonucleases is that, whereas acid
ribonuclease is not inhibited by the rat-liver inhi-
bitor, all the three mammalian alkaline ribo-
nucleases tested, namely those of rat-liver mito-
chondria and supernatant as well as the pancreatic
enzyme, are all inhibited (Shortman, 1962a).
Although mitochondrial alkaline-ribonuclease
activity is present in a free form whereas the super-
natant alkaline-ribonuclease activity is present
along with the inhibitor presumably in combina-
tion, as inferable from observations with use of
thiol-binding agents, it has been shown that purified
alkaline ribonucleases of mitochondria and super-
Table 1. Di8tribution of ribonuclea8e activity in rat-adrenal fraction8 and comparison with
liver cell fractions
Free ribonuclease was determined by following the release of acid-soluble nucleotides on incubation of a 1:10
homogenate or equivalent cell fraction with 2-5mg. of dialysed yeast RNA. Total ribonuclease activity of
mitochondria at pH5-6 or 7-8 was determined in the same manner after freezing and thawing a 1:10 suspension
in water (*) or after treatment with 0-1% (v/v) Triton X-100 (t). The supernatant activity was assayed with and
without preincubation with N-ethylmaleimide (final concn. 3mM). The activities are expressed as ribonuclease
activity units/50 mg. oftissue or equivalent cell fraction. One unit ofribonuclease activity is the amount ofenzyme
releasing acid-soluble nucleotides equivalent to 1 extinction unit under the above conditions. The results are
averages of four independent determinations.
Ribonuclease activity (unit)
Homogenate Mitochondria Supernatant
Free activity
pH5-6 pH7-8
0-100 0-108
Total activity
pH5-6 pH7-8
0.398* 0.108*
0-412t 0-112t
0-342* 0-118*
0-400t 0-121t
Liver 0-250
Tissue
Adrenals
Free activity
pH7-8
0-305
- N-Ethyl-
maleimide
pH7-8
0-095
+ N-Ethyl-
maleimide
pH7-8
0-280
PI,Al 1966
0-124 0-124 0.080 0-220
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Fig. 2. Effect of N-ethylmaleimide on the inhibition of
crystalline pancreatic ribonuclease by adrenal supernatant
fraction. The assay system consisted of 10-Oml. of 50mM-
veronal-acetate buffer, pH7*8, 10ml. of 1% dialysed yeast
RNA, 10,ug. of crystalline pancreatic ribonuclease, 4-0ml.
of 1:10 supernatant and, where indicated, N-ethylmale-
imide (final concn. 3mm). The total volume was 25ml.
Samples (4-0ml.) were added after 0, 10, 20, 30 and 40min.
to 4-0ml. of precipitating reagent [N-HCI in 76% (v/v)
ethanol containing LaCl3,7H20 (0.5%)]. The supernatant
was diluted 1:50 and readings were taken at 260mu. The
plots represent the averages of three independent experi-
ments. Curve 1, activity of adrenal supernatant alone;
curve 2, activity of supernatant fraction preincubated with
N.ethylmaleimide; curve 3, activity of crystalline pancrea-
tic ribonuclease; curve 4, activity of crystalline pancreatic
ribonuclease in the presence of supernatant; curve 5,
activity of crystalline pancreatic ribonuclease in the
presence of supernatant and N-ethylmaleimide.
natant are identical in their specificity towards sub-
strates (Nodes et al. 1962; Beard & Razzell, 1964).
A time-course study of the action of N-ethyl-
maleimide on the adrenal supernatant fraction is
shown in Fig. 2. The ribonuclease activity in the
supernatant fraction is low (curve 1). On the
addition of N-ethylmaleimide, a threefold increase
in activity is observable (curve 2), indicating a
bound form of ribonuclease in the supernatant
fraction, and that this is released on inactivation
of the inhibitor by thiol-binding reagents like
N-ethylmaleimide. However, the supernatant
fraction is not saturated with respect to ribo-
nuclease, since considerable amounts of crystalline
enzyme may be inactivated by the addition of
supernatant fraction (curves 3 and 4). This inhibi-
tion is overcome in the presence of N-ethylmale-
imide (curve 5).
The results of two typical experiments to test
the heat-sensitivity of the inhibitor are given in
Table 2. Effect of heating the 8upernatantfraction on
the activity of ribonuclea8se inhibitor
Samples (2ml.) of adrenal supernatant fraction were
placed in test tubes and heated in a water bath for 5min.
at the different temperatures. After heating, the samples
were cooled and assayed for inhibitor activity. The system
for the assay of ribonuclease inhibitor consisted of 0-2ml.
of supernatant fraction, 0-15ml. of 50mM-EDTA, pH7.8,
0.125,ug. of crystalline pancreatic ribonuclease, 1 0ml. of
50mM-veronal-acetate buffer, pH7-8, and 1-Oml. of 1%
RNA solution in a final volume of 3-Oml. The reaction was
stopped after 30min. incubation at 370 by adding 3-Oml.
of precipitating reagent [N-HCI in 76% (v/v) ethanol con-
taining LaCI3,7H20 (0.5%)]. Release of acid-soluble
nucleotides was estimated by the change in extinction at
260m,u. The unit of inhibitor is equivalent to the inhibitor
concentration causing 50% inhibition of 0-005/jug. of
crystalline pancreatic ribonuclease. The results are
averages of two experiments.
Temperature
370
45
55
65
Inhibitor activity
(units/mg. of
protein)
13-6
12-4
5-8
0
Decrease of
inhibitor
activity (%)
9
57
100
Table 3. Purification of sheep-adrenal
ribonuclea8e inhibitor
The supernatant fraction was subjected to (NH4)2SO4
precipitation and treatment with calcium phosphate gel
according to the procedure described in the text. The
eluate from calcium phosphate gel was adsorbed on DEAE-
cellulose columns. The conditions of adsorption and
elution are given in the text. One unit of inhibitor is
equivalent to the inhibitor concentration causing 50%
inhibition of 0-005,ug. of crystalline pancreatic ribo-
nuclease. The results are averages of two independent
experiments carried out with separate batches of sheep
adrenals.
Stage (
Supernatant
55% satd. (NH4)2SO4
precipitate
Eluate from calcium
phosphate gel
Eluate from DEAE-
cellulose column
chromatography
Specific
activity
Activity (units/mg.
units/ml.) of protein)
420
420
630
5640
15
52
Recovery
(%)
100
85
174 58
6300 80
Table 2. The inhibitor is relatively heat-sensitive,
being completely destroyed after heating for 5min.
at 650. Together with the fact that the inhibitor is
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non-diffusible in crude as well as in purified prepara-
tions, the observation suggests that it may be
protein in nature.
The inhibitor activity could be purified several
hundred-fold by employing methods used for the
purification of proteins. An analysis of the results
of a standard purification procedure is presented in
Table 3. Initial purification was carried out by
combined ammonium sulphate precipitation and
calcium phosphate gel treatment. The specific
activity of the inhibitor preparation thereby in-
creased 10-12-fold; the partially purified inhibitor
was next passed through a column of DEAE-
cellulose. All of the inhibitor activity was retained
on the column. Elution was carried out with a
linear gradient of 0-15-1-5M-sodium chloride buf-
fered at pH6-4 with tris. The highest inhibitor
concentrations were obtained in fractions 13, 14,
15 and 16. These eluate fractions also contained
most of the 280m,u-absorbing material. A 400-
500-fold purification was thus attained.
Though an analysis of the purified inhibitor
preparation has not been undertaken, previous
studies also indicate that protein forms the major
constituent in purified rat-liver inhibitor prepara-
tions. No other component was present to any
considerable extent (Shortman, 1962a).
The protein nature of the inhibitor (Shortman,
1961), as well as its lability in vivo (Roth, 1956b;
Shortman, 1962b; Girija et al. 1965), lead one to
speculate that the inhibitor may play an important
role in the regulation ofRNAmetabolism, especially
in view of recent reports implicating ribonuclease
as the enzyme involved in the degradation of
rapidly turned over RNA in bacterial (Artman &
Engelberg, 1964) as well as in animal systems
(Harris, 1963).
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